Delivery Order SPE2DB22D2206-SPE2DB25FGU35
Award Date
4/30/25
Potential Completion Date
5/21/25
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets. The contract, which is not set aside, has a ceiling value of $2,589.70 and a completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, branded and generic drugs, vaccines, and...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of the prescription drug Mekinist 0.5 mg tablet, with a ceiling value of $8,552.49 and a period of performance through May 23, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $10,358.80 order is for the supply of Mekinist 0.5 mg tablets in support of military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as...
This is a $8,878.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide 4563518616 Mekinist 2 mg tablets, with a completion date of February 23, 2024. This contract is a part of AmerisourceBergen's broader Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,670.51, is for the delivery of Mekinist 2 mg tablets, a prescription medication. The delivery order has a firm fixed price and an ultimate completion date of May 23, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $18,371.32 fixed-price award is for the delivery of 4,566,462,969 units of the drug MEKINIST 2 MG Tablet with a completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the award is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of MEKINIST 2 MG TABLET. The contract has a ceiling value of $8,878.79 and a period of performance through September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this firm fixed-price contract to provide the specified medication to support federal healthcare programs and military treatment facilities. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,589.70 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Mekinist 0.5 mg tablets and has an ultimate completion date of June 28, 2024. Amerisourcebergen Drug Corp's Corporate Office Division holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a $5,053.45 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply Mekinist 0.05 mg/ml solution 90ml. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
This is a delivery order under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at up to $999,999,999 through December 2025, provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order, valued at $8,878.79, is for the Mekinist 2 mg tablet drug product. The...